Report: Global non-hematological cancers market will double to $141B by 2021 April 11, 2016 CenterWatch Staff
Philips Volcano enrolls 5,000 coronary artery disease patients in iFR outcomes trials April 8, 2016 CenterWatch Staff
Positive results for Newron phase II study of evenamide for schizophrenia April 6, 2016 CenterWatch Staff